These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1310581)

  • 21. Potentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26).
    Rappa G; Lorico A; Sartorelli AC
    Int J Cancer; 1992 Jul; 51(5):780-7. PubMed ID: 1377186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus replication in human retinal pigment epithelial cells. Altered expression of viral early proteins.
    Detrick B; Rhame J; Wang Y; Nagineni CN; Hooks JJ
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):814-25. PubMed ID: 8603866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?
    Gewirtz DA
    Biochem Pharmacol; 1991 Nov; 42(12):2253-8. PubMed ID: 1662508
    [No Abstract]   [Full Text] [Related]  

  • 24. Suramin inhibits DNA damage in human prostate cancer cells treated with topoisomerase inhibitors in vitro.
    Yamazaki H; Dilworth A; Myers CE; Sinha BK
    Prostate; 1993; 23(1):25-36. PubMed ID: 8393191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
    Woynarowski JM; Sigmund RD; Beerman TA
    Biochim Biophys Acta; 1988 May; 950(1):21-9. PubMed ID: 2833925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.
    Zwelling LA; Mayes J; Hinds M; Chan D; Altschuler E; Carroll B; Parker E; Deisseroth K; Radcliffe A; Seligman M
    Biochemistry; 1991 Apr; 30(16):4048-55. PubMed ID: 1850298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mood stabilizers inhibit cytomegalovirus infection.
    Ornaghi S; Davis JN; Gorres KL; Miller G; Paidas MJ; van den Pol AN
    Virology; 2016 Dec; 499():121-135. PubMed ID: 27657833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human cytomegalovirus immediate-early gene expression and replication by the ethyl acetate (EtOAc) fraction of Elaeocarpus sylvestris in vitro.
    Bae S; Kang SC; Song YJ
    BMC Complement Altern Med; 2017 Aug; 17(1):428. PubMed ID: 28851336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.
    Zwelling LA; Slovak ML; Doroshow JH; Hinds M; Chan D; Parker E; Mayes J; Sie KL; Meltzer PS; Trent JM
    J Natl Cancer Inst; 1990 Oct; 82(19):1553-61. PubMed ID: 1976136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of active cytomegalovirus infection by analysis of immediate-early, early and late transcripts in peripheral blood cells of immunodeficient patients.
    Meyer T; Reischl U; Wolf H; Schüller C; Arndt R
    Mol Cell Probes; 1994 Aug; 8(4):261-71. PubMed ID: 7870068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8.
    Murayama T; Kuno K; Jisaki F; Obuchi M; Sakamuro D; Furukawa T; Mukaida N; Matsushima K
    J Virol; 1994 Nov; 68(11):7582-5. PubMed ID: 7933146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
    Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
    Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
    D'Arpa P; Beardmore C; Liu LF
    Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
    Emery VC; Sabin C; Feinberg JE; Grywacz M; Knight S; Griffiths PD
    J Infect Dis; 1999 Sep; 180(3):695-701. PubMed ID: 10438356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An etoposide-induced block in vaccinia virus telomere resolution is dependent on the virus-encoded DNA ligase.
    DeLange AM; Carpenter MS; Choy J; Newsway VE
    J Virol; 1995 Apr; 69(4):2082-91. PubMed ID: 7884854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
    Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermia, thermotolerance and topoisomerase II inhibitors.
    Kampinga HH
    Br J Cancer; 1995 Aug; 72(2):333-8. PubMed ID: 7640214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein.
    Mercorelli B; Luganini A; Celegato M; Palù G; Gribaudo G; Loregian A
    Antiviral Res; 2018 Feb; 150():130-136. PubMed ID: 29274844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.
    Ellis AL; Nowak B; Plunkett W; Zwelling LA
    Cancer Chemother Pharmacol; 1994; 34(3):249-56. PubMed ID: 8004759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.